In 2017 NICE is due to commence the review of this guidance, to register as a stakeholder please contact us at email@example.com
NICE has developed medical technology guidance on the Mega Soft Patient Return Electrode.
NICE medical technologies guidance addresses specific technologies notified to NICE by sponsors. The ‘case for adoption’ is based on the claimed advantages of introducing the specific technology compared with current management of the condition. This ‘case’ is reviewed against the evidence submitted and expert advice.
NICE has said that the Mega Soft Patient Return Electrode may have advantages for certain people, for example those who would need to shave before the electrode was attached, and those with fragile or damaged skin. This includes people with burns, people with skin conditions, children and older people.
Hospital teams may want to use the Mega Soft Patient Return Electrode because it may reduce the overall risk of burns during monopolar electrosurgery if good standards of operating theatre practice are also followed, may be quicker and easier to use than standard equipment, and will cost about the same.
Next review: April 2017
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.